SMMT logo

Summit Therapeutics Inc. (SMMT) Cash from investing

annual CFI:

-$205.34M+$382.43M(+65.06%)
December 31, 2024

Summary

  • As of today (August 31, 2025), SMMT annual cash flow from investing activities is -$205.34 million, with the most recent change of +$382.43 million (+65.06%) on December 31, 2024.
  • During the last 3 years, SMMT annual CFI has fallen by -$205.03 million (-67004.90%).
  • SMMT annual CFI is now -9235.20% below its all-time high of $2.25 million, reached on January 31, 2010.

Performance

1-year change

+65.06%

3-year change

-67004.9%

5-year change

-60188.02%

15-year change

-2906.41%

SMMT Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

11.99%
SMMT annual cash flow from investing activities is higher than 11.99% of companies in Healthcare sector

Range

All-time high

$2.25M
SMMT annual cash flow from investing activities is currently -9235.20% below its historical high of $2.25 million

3-year low

-$587.77M

Earnings dates

Last annual earnings report date

Dec 31, 2024
SMMT previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
SMMT next annual earnings announcement has not yet been scheduled

OtherSMMTcash flow metrics

annual CFF

$381.23M
SMMT annual cash flow from financing activities is $381.23 million

annual CFO

-$142.11M
SMMT annual cash flow from operations is -$142.11 million

annual FCF

-$142.25M
SMMT annual free cash flow is -$142.25 million

annual CAPEX

$139.00K
SMMT annual capital expenditures is $139.00 thousand

quarterly CFI:

$160.17M+$56.00K(+0.03%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT quarterly cash flow from investing activities is $160.17 million, with the most recent change of +$56.00 thousand (+0.03%) on June 30, 2025.
  • Over the past year, SMMT quarterly CFI has increased by +$359.81 million (+180.23%).
  • SMMT quarterly CFI is now at all-time high.

Performance

3-month change

+0.03%

1-year change

+180.23%

3-year change

+59006.22%

5-year change

+125132.01%

SMMT quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.03%
SMMT quarterly cash flow from investing activities is higher than 99.03% of companies in Healthcare sector

Range

All-time high

$160.17M
SMMT quarterly cash flow from investing activities is currently at an all-time high

3-year low

-$645.06M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
SMMT previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 6, 2025
SMMT next earnings announcement is scheduled for Nov 6, 2025

OtherSMMTcash flow metrics

quarterly CFF

$2.52M
SMMT quarterly cash flow from financing activities is $2.52 million

quarterly CFO

-$70.59M
SMMT quarterly cash flow from operations is -$70.59 million

quarterly FCF

-$70.61M
SMMT quarterly free cash flow is -$70.61 million

quarterly CAPEX

$12.70K
SMMT quarterly capital expenditures is $12.70 thousand

TTM CFI:

$294.10M+$359.81M(+547.59%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT TTM cash flow from investing activities is $294.10 million, with the most recent change of +$359.81 million (+547.59%) on June 30, 2025.
  • Over the past year, SMMT TTM CFI has increased by +$405.87 million (+363.14%).
  • SMMT TTM CFI is now at all-time high.

Performance

3-month change

+547.59%

1-year change

+363.14%

3-year change

+39768.56%

5-year change

+91351.23%

SMMT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.15%
SMMT TTM cash flow from investing activities is higher than 98.15% of companies in Healthcare sector

Range

All-time high

$294.10M
SMMT TTM cash flow from investing activities is currently at an all-time high

3-year low

-$661.01M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
SMMT previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 6, 2025
SMMT next earnings announcement is scheduled for Nov 6, 2025

OtherSMMTcash flow metrics

TTM CFF

$192.34M
SMMT TTM cash flow from financing activities is $192.34 million

TTM CFO

-$211.30M
SMMT TTM cash flow from operations is -$211.30 million

TTM FCF

-$211.81M
SMMT TTM free cash flow is -$211.81 million

TTM CAPEX

$507.30K
SMMT TTM capital expenditures is $507.30 thousand

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SMMT Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+65.1%+180.2%+363.1%
3 y3 years-10000.0%+10000.0%+10000.0%
5 y5 years-10000.0%+10000.0%+10000.0%

SMMT Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+65.1%at high+124.8%at high+144.5%
5 y5-year<-9999.0%+65.1%at high+124.8%at high+144.5%
alltimeall time-9235.2%+65.1%at high+124.8%at high+144.5%

SMMT Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$160.17M(+0.0%)
$294.10M(-547.6%)
Mar 2025
-
$160.11M(+81.1%)
-$65.71M(-68.1%)
Dec 2024
-$205.34M(-65.1%)
$88.43M(-177.2%)
-$205.95M(-6.4%)
Sep 2024
-
-$114.60M(-42.6%)
-$219.98M(+96.8%)
Jun 2024
-
-$199.64M(-1104.7%)
-$111.77M(-242.7%)
Mar 2024
-
$19.87M(-73.3%)
$78.32M(-113.4%)
Dec 2023
-$587.77M(>+9900.0%)
$74.39M(-1264.6%)
-$586.62M(-11.3%)
Sep 2023
-
-$6.39M(-33.2%)
-$661.01M(+1.0%)
Jun 2023
-
-$9.56M(-98.5%)
-$654.58M(+1.4%)
Mar 2023
-
-$645.06M(>+9900.0%)
-$645.30M(>+9900.0%)
Dec 2022
-$624.00K(+103.9%)
-$2800.00(-106.7%)
-$594.20K(-15.8%)
Sep 2022
-
$41.50K(-115.3%)
-$705.60K(-4.8%)
Jun 2022
-
-$271.90K(-24.7%)
-$741.40K(+19.2%)
Mar 2022
-
-$361.00K(+216.1%)
-$621.80K(+107.4%)
Dec 2021
-$306.00K(-27.3%)
-$114.20K(-2103.5%)
-$299.80K(+23.4%)
Sep 2021
-
$5700.00(-103.7%)
-$243.00K(-19.7%)
Jun 2021
-
-$152.30K(+290.5%)
-$302.50K(+8.7%)
Mar 2021
-
-$39.00K(-32.1%)
-$278.30K(-35.8%)
Dec 2020
-$421.00K(+23.6%)
-
-
Dec 2020
-
-$57.40K(+6.7%)
-$433.50K(+15.3%)
Sep 2020
-
-$53.80K(-58.0%)
-$376.10K(+16.7%)
Jun 2020
-
-$128.10K(-34.0%)
-$322.30K(+66.0%)
Mar 2020
-
-$194.20K(-40.7%)
-$194.20K(-52.2%)
Dec 2019
-$340.60K(-95.0%)
-
-
Jan 2019
-
-$327.40K(+5356.7%)
-$406.60K(-93.9%)
Oct 2018
-
-$6000.00(-80.8%)
-$6.64M(-0.9%)
Jul 2018
-
-$31.20K(-25.7%)
-$6.69M(-1.2%)
Apr 2018
-
-$42.00K(-99.4%)
-$6.77M(-4.3%)
Jan 2018
-$6.83M
-
-
DateAnnualQuarterlyTTM
Jan 2018
-
-$6.56M(>+9900.0%)
-$7.08M(+1124.0%)
Oct 2017
-
-$63.80K(-42.7%)
-$578.60K(+9.0%)
Jul 2017
-
-$111.30K(-68.2%)
-$531.00K(+18.3%)
Apr 2017
-
-$349.50K(+547.2%)
-$448.70K(+310.9%)
Jan 2017
-$117.30K(+16.8%)
-
-
Jan 2017
-
-$54.00K(+233.3%)
-$109.20K(+75.3%)
Oct 2016
-
-$16.20K(-44.1%)
-$62.30K(-37.5%)
Jul 2016
-
-$29.00K(+190.0%)
-$99.70K(+21.1%)
Apr 2016
-
-$10.00K(+40.8%)
-$82.30K(-15.9%)
Jan 2016
-$100.40K(+75.5%)
-
-
Jan 2016
-
-$7100.00(-86.8%)
-$97.90K(+2.5%)
Oct 2015
-
-$53.60K(+362.1%)
-$95.50K(+237.5%)
Jul 2015
-
-$11.60K(-54.7%)
-$28.30K(-374.8%)
Apr 2015
-
-$25.60K(+444.7%)
$10.30K(-57.3%)
Jan 2015
-$57.20K(-166.4%)
-
-
Jan 2015
-
-$4700.00(-134.6%)
$24.10K(-16.3%)
Oct 2014
-
$13.60K(-49.6%)
$28.80K(+89.5%)
Jul 2014
-
$27.00K(-328.8%)
$15.20K(-228.8%)
Apr 2014
-
-$11.80K
-$11.80K
Jan 2014
$86.20K(-171.4%)
-
-
Jan 2013
-$120.70K(-37.7%)
-
-
Jan 2012
-$193.70K(+3.0%)
-
-
Jan 2011
-$188.00K(-108.4%)
-
-
Jan 2010
$2.25M(-209.9%)
-
-
Jan 2009
-$2.05M(-33.5%)
-
-
Jan 2008
-$3.08M(-16.0%)
-
-
Jan 2007
-$3.66M(+47.6%)
-
-
Jan 2006
-$2.48M(>+9900.0%)
-
-
Jan 2005
-$12.50K(<-9900.0%)
-
-
Jan 2004
$0.00
-
-

FAQ

  • What is Summit Therapeutics Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual CFI year-on-year change?
  • What is Summit Therapeutics Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly CFI year-on-year change?
  • What is Summit Therapeutics Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. TTM CFI year-on-year change?

What is Summit Therapeutics Inc. annual cash flow from investing activities?

The current annual CFI of SMMT is -$205.34M

What is the all time high annual CFI for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual cash flow from investing activities is $2.25M

What is Summit Therapeutics Inc. annual CFI year-on-year change?

Over the past year, SMMT annual cash flow from investing activities has changed by +$382.43M (+65.06%)

What is Summit Therapeutics Inc. quarterly cash flow from investing activities?

The current quarterly CFI of SMMT is $160.17M

What is the all time high quarterly CFI for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly cash flow from investing activities is $160.17M

What is Summit Therapeutics Inc. quarterly CFI year-on-year change?

Over the past year, SMMT quarterly cash flow from investing activities has changed by +$359.81M (+180.23%)

What is Summit Therapeutics Inc. TTM cash flow from investing activities?

The current TTM CFI of SMMT is $294.10M

What is the all time high TTM CFI for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high TTM cash flow from investing activities is $294.10M

What is Summit Therapeutics Inc. TTM CFI year-on-year change?

Over the past year, SMMT TTM cash flow from investing activities has changed by +$405.87M (+363.14%)
On this page